Purinergic signaling to terminate TLR responses in macrophages

Macrophages undergo profound physiological alterations when they encounter pathogen associated molecular patterns (PAMPs). These alterations can result in the elaboration of cytokines and mediators that promote immune responses and contribute to the clearance of pathogens. These innate immune resp...

Full description

Bibliographic Details
Main Authors: Kajal eHamidzadeh, David M Mosser
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00074/full
_version_ 1819264650793975808
author Kajal eHamidzadeh
David M Mosser
author_facet Kajal eHamidzadeh
David M Mosser
author_sort Kajal eHamidzadeh
collection DOAJ
description Macrophages undergo profound physiological alterations when they encounter pathogen associated molecular patterns (PAMPs). These alterations can result in the elaboration of cytokines and mediators that promote immune responses and contribute to the clearance of pathogens. These innate immune responses by myeloid cells are transient. The termination of these secretory responses is not due to the dilution of stimuli, but rather to the active down-regulation of innate responses induced by the very PAMPs that initiated them. Here we describe a purinergic autoregulatory program whereby TLR-stimulated macrophages control their activation state. In this program, TLR stimulated macrophages undergo metabolic alterations that result in the production of ATP and its release through membrane pannexin channels. This purine nucleotide is rapidly hydrolyzed to adenosine by ectoenzymes on the macrophage surface, CD39 and CD73. Adenosine then signals through the P1 class of seven transmembrane receptors to induce a regulatory state that is characterized by the down-regulation of inflammatory cytokines and the production of anti-inflammatory cytokines and growth factors. This purinergic autoregulatory system mitigates the collateral damage that would be caused by the prolonged activation of macrophages, and rather allows the macrophage to maintain homeostasis. The transient activation of macrophages can be prolonged by treating macrophages with IFN-γ. IFN-γ treated macrophages become less sensitive to the regulatory effects of adenosine, allowing them to sustain macrophage activation for the duration of an adaptive immune response.
first_indexed 2024-12-23T20:32:52Z
format Article
id doaj.art-1ea6a7050ee74965bf57c8b122242ea4
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-23T20:32:52Z
publishDate 2016-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-1ea6a7050ee74965bf57c8b122242ea42022-12-21T17:32:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242016-03-01710.3389/fimmu.2016.00074171912Purinergic signaling to terminate TLR responses in macrophagesKajal eHamidzadeh0David M Mosser1University of MarylandUniversity of MarylandMacrophages undergo profound physiological alterations when they encounter pathogen associated molecular patterns (PAMPs). These alterations can result in the elaboration of cytokines and mediators that promote immune responses and contribute to the clearance of pathogens. These innate immune responses by myeloid cells are transient. The termination of these secretory responses is not due to the dilution of stimuli, but rather to the active down-regulation of innate responses induced by the very PAMPs that initiated them. Here we describe a purinergic autoregulatory program whereby TLR-stimulated macrophages control their activation state. In this program, TLR stimulated macrophages undergo metabolic alterations that result in the production of ATP and its release through membrane pannexin channels. This purine nucleotide is rapidly hydrolyzed to adenosine by ectoenzymes on the macrophage surface, CD39 and CD73. Adenosine then signals through the P1 class of seven transmembrane receptors to induce a regulatory state that is characterized by the down-regulation of inflammatory cytokines and the production of anti-inflammatory cytokines and growth factors. This purinergic autoregulatory system mitigates the collateral damage that would be caused by the prolonged activation of macrophages, and rather allows the macrophage to maintain homeostasis. The transient activation of macrophages can be prolonged by treating macrophages with IFN-γ. IFN-γ treated macrophages become less sensitive to the regulatory effects of adenosine, allowing them to sustain macrophage activation for the duration of an adaptive immune response.http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00074/fullAdenosineAutoimmunityGlycolysisATPIFN-γCD73
spellingShingle Kajal eHamidzadeh
David M Mosser
Purinergic signaling to terminate TLR responses in macrophages
Frontiers in Immunology
Adenosine
Autoimmunity
Glycolysis
ATP
IFN-γ
CD73
title Purinergic signaling to terminate TLR responses in macrophages
title_full Purinergic signaling to terminate TLR responses in macrophages
title_fullStr Purinergic signaling to terminate TLR responses in macrophages
title_full_unstemmed Purinergic signaling to terminate TLR responses in macrophages
title_short Purinergic signaling to terminate TLR responses in macrophages
title_sort purinergic signaling to terminate tlr responses in macrophages
topic Adenosine
Autoimmunity
Glycolysis
ATP
IFN-γ
CD73
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00074/full
work_keys_str_mv AT kajalehamidzadeh purinergicsignalingtoterminatetlrresponsesinmacrophages
AT davidmmosser purinergicsignalingtoterminatetlrresponsesinmacrophages